Yasuteru Sano

サノヤステル | Yasuteru Sano

Affiliation and department：

Research field (1)： Neurology

Research theme for competitive and other funds (6)：

2018 - 2021 The elucidation of molecular mechanisms of capillary dysfunction with dermatomyositis.
2017 - 2020 Meanings of auto-antibodies against immune-mediated myositis
2014 - 2017 Establishment of the system eliminating amyloid-beta across the blood-brain barrier
2011 - 2013 Analyses for transport of Amyloid beta through the blood-brain barrier
2009 - 2010 The analysis of the transportation of amyloid-β peptide across the blood-brain barrier

Show all

Papers (89)：

Ryota Sato, Fumitaka Shimizu, Motoi Kuwahara, Yoichi Mizukami, Kenji Watanabe, Toshihiko Maeda, Yasuteru Sano, Yukio Takeshita, Michiaki Koga, Susumu Kusunoki, et al. Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy. Neurology(R) neuroimmunology & neuroinflammation. 2023. 10. 3
Elisa L J Moya, Sonia M Lombardo, Elodie Vandenhaute, Marc Schneider, Caroline Mysiorek, Akif E Türeli, Takashi Kanda, Fumitaka Shimizu, Yasuteru Sano, Nathalie Maubon, et al. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells. International journal of pharmaceutics. 2022. 621. 121780-121780
Miwako Fujisawa, Yukio Takeshita, Susumu Fujikawa, Kinya Matsuo, Masashi Okamoto, Masaya Tamada, Fumitaka Shimizu, Yasuteru Sano, Michiaki Koga, Takashi Kanda. Exploring lipophilic compounds that induce BDNF secretion in astrocytes beyond the BBB using a new multi-cultured human in vitro BBB model. Journal of neuroimmunology. 2022. 362. 577783-577783
Miwako Fujisawa, Yukio Takeshita, Susumu Fujikawa, Kinya Matsuo, Masashi Okamoto, Masaya Tamada, Fumitaka Shimizu, Yasuteru Sano, Michiaki Koga, Takashi Kanda. Exploring lipophilic compounds that induce BDNF secretion in astrocytes beyond the BBB using a new multi-cultured human in vitro BBB model. Journal of Neuroimmunology. 2022. 362. 577783-577783
Fumitaka Shimizu, Ryo Ogawa, Yoichi Mizukami, Kenji Watanabe, Kanako Hara, Chihiro Kadono, Toshiyuki Takahashi, Tatsuro Misu, Yukio Takeshita, Yasuteru Sano, et al. GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder. Neurology(R) neuroimmunology & neuroinflammation. 2022. 9. 1

ｍore...

MISC (64)：

川井元晴, 竹下幸男, 高橋志織, 尾本雅俊, 大石真莉子, 本田真也, 山中菜々美, 佐野泰照, 神田隆, 米沢鉄平. 自己免疫性脳炎の扁桃体腫大に関する検討. 日本神経学会学術大会プログラム・抄録集. 2021. 62nd
神田隆, 清水文崇, 竹下幸男, 門野ちひろ, 佐野泰照, 前田敏彦. 神経免疫疾患のエビデンスによる診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証血液脳関門に注目した多発性硬化症の新規バイオマーカーの探索. 神経免疫疾患のエビデンスによる診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証令和元年度総括・分担研究報告書(Web). 2020
佐野泰照, 尾本雅俊, 古賀道明, 川井元晴, 西野一三, 神田隆. Hereditary myopathy with early respiratory failure(HMERF)と考えられた69歳男性例. 臨床神経学. 2019. 59. 6. 389-389
神田隆, 清水文崇, 古賀道明, 竹下幸男, 藤井菜月美, 佐藤琢磨, 佐藤亮太, 佐野泰照, 前田敏彦. 神経免疫疾患のエビデンスによる診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証血液神経関門に注目したギラン・バレー症候群患者の新規バイオマーカーの探索. 神経免疫疾患のエビデンスによる診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証平成30年度総括・分担研究報告書(Web). 2019
佐野泰照, 佐野宏徳, 清水文崇, 前田敏彦, 尾本雅俊, 神田隆. Establishment of a new human skeletal muscle microvascular endothelial cell line(和訳中). 日本筋学会学術集会プログラム・抄録集. 2018. 4回. 123-123

ｍore...

Work history (2)：

2010/05/18 - 2013/04/05 YAMAGUCHI UNIVERSITY University Hospital Assistant Professor
2010/02/24 - 2010/05/17 YAMAGUCHI UNIVERSITY University Hospital

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page